TRYPTAMINE THERAPEUTICS LIMITED - Corporate Spotlight

Market Cap $21.78M Add to my watchlist

Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology... Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on the development of an advanced and scalable intravenous-infused psilocin formulation, which can be used in conjunction with psychotherapy to address significant unmet medical needs. It is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. It intends to accomplish this through the development of an IV infusion of psilocin (the active metabolite of psilocybin). Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. The Company is engaged in pursuing Phase II clinical trials using its psilocybin and psilocin-based drug products for chronic pain and eating disorders. The Company's pipeline products include TRP-8803 and TRP-8802.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No Corporate Spotlight currently available.

(20min delay)
Last 4.5¢		Change 0.000(0.00%)		Mkt cap ! $21.78M

Open	High	Low	Value	Volume
4.6¢	4.8¢	4.5¢	$85.33K	1.854M

Buyers (Bids)

No.	Vol.	Price($)
4	1431097	4.5¢

Sellers (Offers)

Price($)	Vol.	No.
4.6¢	174969	2

View Market Depth

No.	Vol.	Price($)
2	1208900	0.018
3	2174000	0.017
2	391565	0.016
1	500000	0.015
1	777777	0.013

Price($)	Vol.	No.
0.020	516336	3
0.022	508953	3
0.023	403477	3
0.024	140529	2
0.025	496094	4

Last trade - 15.58pm 22/11/2024 (20 minute delay)


Last 4.5¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
4.6¢	4.8¢	4.5¢	1008422
Last updated 15.57pm 22/11/2024 ?

TYP (ASX) Chart